Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?...[Carta] (2011)
- Authors:
- Autor USP: LEVIN, ANNA SARA SHAFFERMAN - FM
- Unidade: FM
- Subjects: DOENÇAS INFECCIOSAS (CLASSIFICAÇÃO;DIAGNÓSTICO;MORTALIDADE;TERAPIA); INFECÇÃO HOSPITALAR (MORTALIDADE); CULTURA DE CÉLULAS; RESISTÊNCIA MICROBIANA ÀS DROGAS; BACTEREMIA (TERAPIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: The journal of infection
- ISSN: 0163-4453
- Volume/Número/Paginação/Ano: v. 62, n. 3, p. 246-249, 2011
-
ABNT
TUON, Felipe F et al. Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta]. The journal of infection. Kent: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdf. Acesso em: 17 fev. 2026. , 2011 -
APA
Tuon, F. F., Rymsza, A. M., Penteado Filho, S. R., Pilonetto, M., Arend, L. N. V. S., & Levin, A. S. S. (2011). Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta]. The journal of infection. Kent: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdf -
NLM
Tuon FF, Rymsza AM, Penteado Filho SR, Pilonetto M, Arend LNVS, Levin ASS. Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta] [Internet]. The journal of infection. 2011 ; 62( 3): 246-249.[citado 2026 fev. 17 ] Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdf -
Vancouver
Tuon FF, Rymsza AM, Penteado Filho SR, Pilonetto M, Arend LNVS, Levin ASS. Should polymyxin be used empirically to treat infections in patients under high risk for cabapenem resistant Acinetobacter?.[Carta] [Internet]. The journal of infection. 2011 ; 62( 3): 246-249.[citado 2026 fev. 17 ] Available from: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WJT-520J959-1-1&_cdi=6887&_user=5674931&_pii=S0163445311000065&_origin=browse&_zone=rslt_list_item&_coverDate=03%2F31%2F2011&_sk=999379996&wchp=dGLbVzb-zSkWA&md5=51a4d785b63fe85e3dde721dc8520607&ie=/sdarticle.pdf - The challenge of multidrug resistance: the treatment of gram-negative rod infecions
- Treatment of Acinetobacter spp. infections
- Evaluation of cleaning process efficacy of instruments for robotic surgery using the adenosine triphosphate test
- Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department
- Healthcare-associated infections: a threat to the survival of patients with COVID-19 in intensive care units
- Emergência de resistência de psuedomonas auruginosa e acinetobacter SPP após uso de imipenem e ciprofloxacina em uma população de queimados do Hospital das Clínicas de São Paulo
- Tratamento com pele alógena e substitutos dérmicos
- Resistência a antibióticos
- Pichia anomala fungemia: an exogenous infection ?
- Pichia anomala outbreak in a nursery: exogenous source?
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
